Literature DB >> 19828482

Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease.

Michael Orth1, Sven Schippling, Susanne A Schneider, Kailash P Bhatia, Penelope Talelli, Sarah J Tabrizi, John C Rothwell.   

Abstract

BACKGROUND: Cognition is affected early in Huntington disease (HD), and in HD animal models there is evidence that this reflects abnormal synaptic plasticity. The authors investigated whether there is any evidence for abnormal synaptic plasticity using the human motor cortex-rTMS model and, if so, if there is any difference between premanifest HD gene carriers and very early manifest HD patients or any relationship with ratings of the severity of motor signs.
METHODS: Fifteen HD gene carriers (seven premanifest, eight very early manifest) and 14 control participants were given a continuous train of 100 bursts of theta burst stimulation (cTBS: three pulses at 50 Hz and 80% AMT repeated every 200 ms). The size of the motor-evoked potential was measured at regular intervals until 21 min after cTBS.
RESULTS: HD gene carriers and controls responded differently to theta burst stimulation (F(4.9,131.9)=1.37, p=0.048) with controls having more inhibition than HD gene carriers (F(1,27)=13.3, p=0.001). Across all time points, mean inhibition differed between the groups (F(2,26)=6.32, p=0.006); controls had more inhibition than either HD gene carrier subgroup (p=0.006 for premanifest and p=0.009 for early symptomatic), whereas there was no difference between premanifest and early symptomatic HD gene carriers. The measure of cortical plasticity was not associated with any clinical ratings (Unified Huntington Disease Rating Scale motor score, estimate of age at onset).
CONCLUSIONS: Motor cortex plasticity is abnormal in HD gene carriers but is not closely linked to the development of motor signs of HD.

Entities:  

Mesh:

Year:  2009        PMID: 19828482      PMCID: PMC2997479          DOI: 10.1136/jnnp.2009.171926

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  36 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease.

Authors:  I Ferrer; R Blanco
Journal:  Brain Res Mol Brain Res       Date:  2000-05-05

3.  Huntington disease: clinical care and evaluation.

Authors:  I Shoulson; S Fahn
Journal:  Neurology       Date:  1979-01       Impact factor: 9.910

4.  Anterograde transport of brain-derived neurotrophic factor and its role in the brain.

Authors:  C A Altar; N Cai; T Bliven; M Juhasz; J M Conner; A L Acheson; R M Lindsay; S J Wiegand
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

Review 5.  A synaptic model of memory: long-term potentiation in the hippocampus.

Authors:  T V Bliss; G L Collingridge
Journal:  Nature       Date:  1993-01-07       Impact factor: 49.962

6.  Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice.

Authors:  Silvia Gines; Ihn Sik Seong; Elisa Fossale; Elena Ivanova; Flavia Trettel; James F Gusella; Vanessa C Wheeler; Francesca Persichetti; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2003-03-01       Impact factor: 6.150

7.  Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.

Authors:  K P Murphy; R J Carter; L A Lione; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

8.  Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.

Authors:  Tara L Spires; Helen E Grote; Neelash K Varshney; Patricia M Cordery; Anton van Dellen; Colin Blakemore; Anthony J Hannan
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

9.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

10.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  30 in total

Review 1.  Hyperkinetic disorders and loss of synaptic downscaling.

Authors:  Paolo Calabresi; Antonio Pisani; John Rothwell; Veronica Ghiglieri; Josè A Obeso; Barbara Picconi
Journal:  Nat Neurosci       Date:  2016-06-28       Impact factor: 24.884

Review 2.  Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Authors:  Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters
Journal:  J Neurosci Res       Date:  2019-07-28       Impact factor: 4.164

3.  The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.

Authors:  Daniel Ryskamp; Jun Wu; Michal Geva; Rebecca Kusko; Iris Grossman; Michael Hayden; Ilya Bezprozvanny
Journal:  Neurobiol Dis       Date:  2016-11-03       Impact factor: 5.996

Review 4.  Synaptic plasticity in neurodegenerative diseases evaluated and modulated by in vivo neurophysiological techniques.

Authors:  F Pilato; P Profice; F Ranieri; F Capone; R Di Iorio; L Florio; V Di Lazzaro
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

Review 5.  Alteration of GABAergic neurotransmission in Huntington's disease.

Authors:  Maurice Garret; Zhuowei Du; Marine Chazalon; Yoon H Cho; Jérôme Baufreton
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

6.  Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease.

Authors:  Rodolfo G Gatto; Yaping Chu; Allen Q Ye; Steven D Price; Ehsan Tavassoli; Andrea Buenaventura; Scott T Brady; Richard L Magin; Jeffrey H Kordower; Gerardo A Morfini
Journal:  Hum Mol Genet       Date:  2015-06-29       Impact factor: 6.150

7.  Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease.

Authors:  Reena Prity Murmu; Wen Li; Anthony Holtmaat; Jia-Yi Li
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

8.  Monitoring Huntington's disease progression through preclinical and early stages.

Authors:  Chris Tang; Andrew Feigin
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

Review 9.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

10.  Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness.

Authors:  Robert Christian Wolf; Georg Grön; Fabio Sambataro; Nenad Vasic; Nadine Donata Wolf; Philipp Arthur Thomann; Carsten Saft; G Bernhard Landwehrmeyer; Michael Orth
Journal:  Hum Brain Mapp       Date:  2011-08-25       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.